In the context of MS, which also impacts oligodendroglia and has reduced SCD (as seen in MSA), the application of a SCD inhibitor increased colocalization of myelin basic protein (MBP) and neurofilament and promoted myelination of demyelinated axons in ex vivo mouse brain slices.35 Here, SCD is linked to myeloid sarcoma.